Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|June 16, 2026
MTHFD1 Deficiency in Two Unrelated Children: Highlights on Phenotypic Spectrum and Response to Folic Acid TherapyFajer Altammar, Haidy Elsayed, Mohamed Elshinawy, et al.Pediatric Hematology and Oncology|May 21, 2021
Rare inherited coagulation disorders in young children in OmanSurekha Tony, Roshan Mevada, Abdulhakim Al Rawas, et al.Pediatric Blood & Cancer|November 20, 2013
Thiamine responsive megaloblastic anemia: the puzzling phenotypeIsmail Beshlawi, Shoaib Al Zadjali, Wafa Bashir, et al.International Journal of Laboratory Hematology|January 25, 2021
Clinical and molecular characteristics of imerslund-gräsbeck syndrome: First report of a novel Frameshift variant in Exon 11 of AMN geneMohamed Elshinawy, Harry H Gao, Dana M Al-Nabhani, et al.Journal of Pediatric Hematology/Oncology|February 25, 2017
Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic NeutropeniaHanan F Nazir, Mohamed Elshinawy, Abdulhakim AlRawas, et al.Transfusion|March 6, 2020
Sepsis-related anemia in a pediatric intensive care unit: transfusion-associated outcomesMohamed Elshinawy, Maha Kamal, Hanan Nazir, et al.Pediatric Hematology and Oncology|July 31, 2012
T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron storesSurekha Tony, Shahina Daar, Mohamed Elshinawy, et al.Pediatric Hematology and Oncology|October 4, 2013
Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapyMathew Zachariah, Mohamed Elshinawy, Abdulhakim Alrawas, et al.Journal of Pediatric Hematology/Oncology|January 5, 2022
Age of Transition Readiness of Adolescents and Young Adults With Chronic Diseases in Oman: Need an Urgent RevisitReem Abdwani, Muna Al Saadoon, Sanjay Jaju, et al.Hemoglobin|September 11, 2023
Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High DoseDoaa Khater, Sharef Al-Mulaabed, Anwar Alomairi, et al.Pageof 3